• Ocrevus’ Journey from Defiant Idea to Game-Changing Treatment
  • Small Study Shows Unexpected Reversal of Some MS Symptoms
  • Two Women with Different Forms of Multiple Sclerosis Call Ocrevus a Lifesaver
  • Siponimod Slows Progression of MS Disability, Phase 3 Clinical Trial Shows
  • Lemtrada Might Outperform Ocrevus in Preventing MS Relapses, Italian Researchers Say
  • Crossing MS PATHS — and Taking a Stand for Patient Rights
  • MS Patients Seem to Present Earlier Symptoms of Disease Before Diagnosis
  • Latest Research Bolsters My Confidence in Using Tecfidera
  • Genentech Highlights Rapid Actions of MS Therapy Ocrevus at AAN Meeting
  • 39 Years and Counting — on at Least 39 More Great Ones
  • Sanofi Genzyme to Present New Data on MS Treatments Lemtrada and Aubagio
  • Why the Future of Science Is Crucial to the MS Community
  • Bioinformatics Approach Identifies Potential Therapies Targeting TNF, a Factor in MS, Other Diseases